U.S. Pharma Stock News

Newmont (NYSE:NEM) is transitioning its Chief Technical Officer role as long-serving EVP and CTO Francois Hardy retires after a 24-year career with the company. Erin Workman, a seasoned internal technical leader, has been appointed acting CTO, assuming responsibility for exploration, technical services, and portfolio optimization. The succession reflects a planned leadership change in a core operational role that supports Newmont's mine portfolio and future project pipeline. Newmont is one...

LegalZoom.com (LZ) opened 2026 with Q1 revenue of US$206.8 million and basic EPS of roughly US$0.01, alongside net income of US$1.1 million, setting a measured tone for its latest update. Over recent quarters the company has seen revenue move from US$161.7 million in Q4 2024 to US$183.1 million in Q1 2025 and then to US$206.8 million in Q1 2026. Over the same period, quarterly basic EPS shifted from US$0.07 to US$0.03 and now sits just above breakeven, putting the focus squarely on how...

Envista Holdings (NVST) opened 2026 with Q1 revenue of US$705.5 million and basic EPS of US$0.24, alongside trailing twelve month revenue of about US$2.8 billion and EPS of US$0.41 that reflects the company being in profit over the last year. The company has seen quarterly revenue move from US$616.9 million and EPS of US$0.10 in Q1 2025 to US$705.5 million and EPS of US$0.24 in Q1 2026. Over the same period, the trailing twelve month line has shifted from a large loss a year ago to net income...

NANO Nuclear Energy (NNE) drew fresh attention after signing a memorandum of understanding with Super Micro Computer to explore using its microreactors for on site, grid independent power at AI focused data centers. See our latest analysis for NANO Nuclear Energy. That surge on the Super Micro Computer MOU has contributed to a 30 day share price return of 32.77% and a 7 day return of 14.20%. The stock is still posting a 90 day share price decline of 8.56% and a modest year to date share price...

Greenbrier Leasing Company previously secured a new US$425 million non-recourse term loan, refinancing an earlier facility and extending its maturity to May 2032, with US$125 million in delayed draw commitments earmarked for secondary-market railcar purchases during fiscal 2026. This refinancing underpins Greenbrier’s aim to expand its lease fleet and increase recurring leasing income, shifting more of its business mix toward steadier cash flows. We’ll now examine how this extended-maturity,...

Zeta Global Holdings Corp. reported past first-quarter 2026 results with sales of US$396.3 million versus US$264.42 million a year earlier, while net loss narrowed to US$13.25 million from US$21.6 million. Alongside these results, Zeta raised its 2026 revenue outlook to US$1.78–US$1.79 billion and signaled expectations for positive GAAP net income, citing strength from the Marigold acquisition and its AI platform Athena. Against this backdrop of higher full-year revenue guidance, we’ll now...

EZCORP, Inc. reported past second-quarter 2026 results with revenue of US$446.88 million and net income of US$49.1 million, sharply higher than the prior year, alongside stronger basic and diluted earnings per share from continuing operations. Management highlighted increased pawn loan demand, higher jewelry scrap activity, recent store acquisitions, and a new US$50 million share repurchase authorization as key drivers of the improved performance and financial flexibility. Next, we’ll...

1-800-FLOWERS.COM (FLWS) has just posted Q3 2026 results with revenue of US$293.0 million and a basic EPS loss of US$1.56, while net income excluding extra items was a loss of US$100.1 million. The company has seen quarterly revenue move between US$331.5 million and US$775.5 million since Q3 2025, with EPS ranging from a loss of US$2.80 to a profit of US$1.11 over that period. Trailing twelve month EPS now sits at a loss of US$2.11 on revenue of about US$1.5 billion and a net loss of US$134.4...

Chimera Investment (CIM) opened 2026 with Q1 total revenue of US$47.0 million and basic EPS of a US$0.78 loss, setting a cautious tone around the latest financial update. Over the past year, quarterly revenue has moved between US$38.2 million and US$201.0 million, while basic EPS has ranged from a US$2.06 loss to US$1.79, giving you a wide band of outcomes to weigh as you consider how sustainable current margins are. See our full analysis for Chimera Investment. With the headline numbers on...

OraSure Technologies (OSUR) opened 2026 with Q1 revenue of US$27.9 million and a basic EPS loss of US$0.32, alongside a trailing twelve month revenue base of US$113.0 million and a basic EPS loss of US$1.04. Over recent quarters the company has seen revenue move from US$29.9 million in Q1 2025 and US$37.4 million in Q4 2024 to the latest US$27.9 million print. Quarterly basic EPS losses shifted from US$0.21 and US$0.14 in those periods to US$0.32, so investors are likely to focus on how...

Brighthouse Financial (BHF) opened 2026 with Q1 revenue of US$1.5b and a basic EPS loss of US$13.72, alongside net income excluding extra items of a US$792m loss. On a trailing 12 month basis, revenue stood at US$6.1b with a basic EPS loss of US$2.92 and a US$167m net loss. Over recent quarters the company has seen revenue move from US$2.4b in Q1 2025 to US$1.9b in Q4 2025 and US$1.5b in Q1 2026. Basic EPS has ranged from a loss of US$5.05 in Q1 2025 to a profit of US$10.80 in Q4 2024 before...

Radian Group (RDN) opened 2026 with Q1 revenue of US$466.3 million and basic EPS of US$0.94, setting the tone for how its earnings story is evolving against a trailing twelve month backdrop of US$1.37 billion in revenue and EPS of US$4.34. Over recent quarters, the company has seen revenue move between US$292.7 million and US$318.1 million, while quarterly EPS has ranged from US$0.99 to US$1.16, giving investors a clear look at how the latest print fits into its recent track record. With...

ATN International (ATNI) opened 2026 with Q1 revenue of US$182.2 million and a basic EPS loss of US$0.18, while trailing 12 month revenue stood at US$730.9 million against a net loss of US$14.9 million. Over recent quarters, revenue has moved in a tight band between US$179.3 million and US$184.2 million. During the same period, basic EPS has swung from a profit of US$0.18 in Q3 2025 to losses of US$0.56 in Q2 2025 and US$0.32 in Q4 2025. This sets up a quarter where investors are focused less...

M&T Bank is actively assessing targeted acquisitions within its 13 state footprint to increase regional scale. The company is focusing on adding density in existing markets rather than pursuing a national expansion strategy. This comes as regulators appear more open to bank mergers, creating a more supportive backdrop for deals. M&T Bank (NYSE:MTB) is sharpening its focus on regional growth, with management exploring acquisitions that fit within its existing footprint instead of chasing...

MBX Biosciences, Inc. recently reported first-quarter 2026 results, posting a US$23.58 million net loss and basic and diluted loss per share of US$0.51, both improving slightly from the same period in 2025. Alongside the earnings report, director Steven L. Hoerter received a mix of restricted stock units and stock options, underlining the company’s use of equity-based incentives tied to ongoing service. We’ll now examine how MBX Biosciences’ narrower quarterly loss and equity awards for its...

FY 2026 earnings snapshot and how the stories stack up NVE (NVEC) has just wrapped up FY 2026 with fourth quarter revenue of US$7.7 million and basic EPS of US$1.02, set against trailing twelve month revenue of US$26.3 million and EPS of US$3.14 as the stock trades at US$88.59. Over recent quarters the company has seen revenue range from US$6.1 million to US$7.7 million and quarterly EPS move between US$0.68 and US$1.02. This gives investors a clearer read on how the topline and per share...

Mirum Pharmaceuticals (MIRM) just posted Q1 2026 results with revenue of US$159.9 million, a basic EPS loss of US$13.43 and net income loss excluding extra items of US$790.2 million. The company has reported quarterly revenue of US$99.4 million in Q4 2024, US$111.6 million in Q1 2025, US$127.8 million in Q2 2025, US$133.0 million in Q3 2025 and US$148.9 million in Q4 2025, while EPS over those periods ranged between a loss of US$0.50 and a profit of US$0.06. For investors, a key focus this...

In recent months, Marvell Technology has reshaped its AI infrastructure profile through Nvidia’s US$2 billion investment and partnership, reported co-development talks with Alphabet on new AI chips, and the acquisitions of Celestial AI and Polariton Technologies to deepen its optical interconnect capabilities. Together, these moves signal Marvell’s push to become a core supplier of custom silicon and high-speed networking for hyperscale AI data centers that increasingly depend on specialized...

Hagerty (HGTY) opened 2026 with Q1 revenue of US$311.8 million and a basic EPS loss of US$0.06, as net income swung to a loss of US$6.5 million. The company has seen quarterly revenue shift from US$319.6 million and EPS of US$0.07 in Q1 2025 to US$311.8 million and an EPS loss of US$0.06 in Q1 2026, against a trailing twelve month EPS of US$0.26. This sets up a mixed start to the year, with margins firmly in focus for investors parsing this update. See our full analysis for Hagerty. With the...

Baron Health Care Fund recently highlighted Roivant Sciences (NasdaqGS:ROIV) for positive Phase 2 results of brepocitinib in cutaneous sarcoidosis. The fund called brepocitinib's data a potential major catalyst and suggested the market may be underestimating the drug's franchise value. This public endorsement draws fresh attention to Roivant's pipeline beyond earlier discussions about its valuation or analyst coverage. Roivant Sciences focuses on developing and commercializing therapies...

Camtek (CAMT) stock was in focus after the company reported record revenues and operating income, tied to high performance computing and advanced packaging for AI related applications, and outlined its expectations for growth into 2026. See our latest analysis for Camtek. The stock has been volatile around the results, with a 1-day share price decline of 4.67%, but a 30-day share price return of 21.27% and a 1-year total shareholder return approaching 3x. This points to strong momentum that...

Recent analyst actions around Home Depot (HD), including renewed coverage highlighting its Pro contractor focus and recent earnings that topped muted expectations, have pulled the stock back into the spotlight despite ongoing housing and spending headwinds. See our latest analysis for Home Depot. At a recent share price of US$322.64, Home Depot has seen pressure with a 90 day share price return of 16.23% and a year to date share price return of a 6.70% decline. The 3 year total shareholder...

Why Freshpet’s latest earnings matter for investors Freshpet (FRPT) just posted first quarter results showing sales of US$297.64 million and net income of US$48.51 million, compared with a net loss a year earlier. This has drawn fresh attention to the stock. See our latest analysis for Freshpet. Freshpet’s latest results and brand campaign land against a weaker price backdrop, with a 30 day share price return of 11.37% and a 1 year total shareholder return decline of 31.9%, suggesting longer...

Garrett Motion (GTX) recently reported Q1 2026 results alongside a higher full year outlook, combining stronger quarterly figures, new industrial contracts and progress in zero emission technologies to shape how investors are reassessing the stock. See our latest analysis for Garrett Motion. The recent Q1 release and raised full year guidance have coincided with a strong shift in sentiment, with a 49.34% 1 month share price return and a very large 5 year total shareholder return, suggesting...